SynBiotic SE/€SBX

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About SynBiotic SE

SynBiotic SE is a German company specializing in the research, development, production, and marketing of cannabinoid and terpene-based products aimed at addressing conditions such as pain, sleep deprivation, and anxiety. Its product portfolio includes hemp-derived dietary supplements, cosmetics, medical cannabis products, and recreational cannabis items, marketed under brands like Hempamed, Princess Stardust, The Hempany, and Hempamed Rx. Originally known as Ledgertech SE, the company rebranded to SynBiotic SE and is headquartered in Munich, Germany. Through strategic acquisitions, such as the 2024 purchase of WEECO Pharma GmbH, SynBiotic has expanded its presence in the European medical cannabis market. The company operates across the entire value chain, from cultivation to retail, positioning itself as a comprehensive player in the hemp and cannabis industry. (,)

Ticker

€SBX

Primary listing

XETRA

Industry

Pharmaceuticals
Headquarters

Employees

55

SynBiotic SE Metrics

BasicAdvanced
€24M
-
-€2.24
4.54
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SBX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs